BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12730231)

  • 1. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
    Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
    Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
    Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
    Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
    Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
    Bharadwaj A; Kempster E; Waisman DM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of plasmin activity by annexin II tetramer.
    Fitzpatrick SL; Kassam G; Choi KS; Kang HM; Fogg DK; Waisman DM
    Biochemistry; 2000 Feb; 39(5):1021-8. PubMed ID: 10653646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of annexin II tetramer in the activation of plasminogen.
    Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
    J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
    Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
    J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer.
    Choi KS; Fitzpatrick SL; Filipenko NR; Fogg DK; Kassam G; Magliocco AM; Waisman DM
    J Biol Chem; 2001 Jul; 276(27):25212-21. PubMed ID: 11319229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M; Waisman DM
    Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of annexin II tetramer in plasminogen activation.
    Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
    Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARĪ± fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Ca2+-binding sites of annexin II tetramer.
    Filipenko NR; Kang HM; Waisman DM
    J Biol Chem; 2000 Dec; 275(49):38877-84. PubMed ID: 10980196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.
    Cesarman GM; Guevara CA; Hajjar KA
    J Biol Chem; 1994 Aug; 269(33):21198-203. PubMed ID: 8063741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes.
    Laumonnier Y; Syrovets T; Burysek L; Simmet T
    Blood; 2006 Apr; 107(8):3342-9. PubMed ID: 16373665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.